Angiopoietin
Chr. 8 q22.3-8q23 | |||||||
---|---|---|---|---|---|---|---|
|
Chr. 8 p23 | |||||||
---|---|---|---|---|---|---|---|
|
Angiopoietin is part of a family of vascular
In addition, there are a number of proteins that are closely related to ('like') angiopoietins (Angiopoietin-related protein 1, ANGPTL2, ANGPTL3, ANGPTL4, ANGPTL5, ANGPTL6, ANGPTL7, ANGPTL8).[5]
Angiopoietin-1 is critical for vessel maturation, adhesion, migration, and survival. Angiopoietin-2, on the other hand, promotes cell death and disrupts vascularization. Yet, when it is in conjunction with vascular endothelial growth factors, or
Structure
Angiopoietin-1 encodes a 498 amino acid
Only clusters/multimers activate receptors
Angiopoietin-1 and angiopoietin-2 can form dimers, trimers, and tetramers. Angiopoietin-1 has the ability to form higher order multimers through its super clustering domain. However, not all of the structures can interact with the tyrosine kinase receptor. The receptor can only be activated at the tetramer level or higher.[6]
Specific mechanisms
Tie pathway
The collective interactions between angiopoietins,
Tie-2
Tie-2/Ang-1 signaling activates β1-
Angiopoietin proteins 1 through 4 are all
The expression of Angiopoietin-2 in the absence of vascular endothelial growth factor (VEGF) leads to endothelial cell death and vascular regression.[10] Increased levels of Ang2 promote tumor angiogenesis, metastasis, and inflammation. Effective means to control Ang2 in inflammation and cancer should have clinical value.[11] Angiopoeitin, more specifically Ang-1 and Ang-2, work hand in hand with VEGF to mediate angiogenesis. Ang-2 works as an antagonist of Ang-1 and promotes vessel regression if VEGF is not present. Ang-2 works with VEGF to facilitate cell proliferation and migration of endothelial cells.[12] Changes in expression of Ang-1, Ang-2 and VEGF have been reported in the rat brain after cerebral ischemia.[13][14]
Angiogenesis signaling
To migrate, the endothelial cells need to loosen the endothelial connections by breaking down the
Vascular permeability signaling
Angiopoietin-1 and angiopoietin-2 are modulators of endothelial permeability and barrier function. Endothelial cells secrete angiopoietin-2 for
Cancer
Angiopoietin-2 has been proposed as a biomarker in different cancer types. Angiopoietin-2 expression levels are proportional to the cancer stage for both small and non-small cell lung cancers. It has been also implicated to play role in hepatocellular and endometrial carcinoma-induced angiogenesis. Experiments using blocking antibodies for angiopoietin-2 have shown to decrease metastasis to lungs and lymph nodes.[16]
Clinical relevance
Deregulation of angiopoietin and the tyrosine kinase pathway is common in blood-related diseases such as diabetes, malaria,[17] sepsis, and pulmonary hypertension. This[clarification needed] is demonstrated by an increased ratio of angiopoietin-2 and angiopoietin-1 in blood serum. To be specific, angiopoietin levels provide an indication for sepsis. Research on angiopoietin-2 has shown that it is involved in the onset of septic shock. The combination of fever and high levels of angiopoietin-2 are correlated with a greater prospect of the development of septic shock. It has also been shown that imbalances between angiopoietin-1 and angiopoietin-2 signaling can act independently of each other. One angiopoietin factor can signal at high levels while the other angiopoieting factor remains at baseline level signaling.[2]
Angiopoietin-2 is produced and stored in
Serum levels of angiopoietin-2 expression are associated with the growth of
Angiopoietin-2 is elevated in patients with angiosarcoma.[22]
Research has shown angiopoietin signaling to be relevant in treating cancer as well. During tumor growth, pro-angiogenic molecules and anti-angiogenic molecules are off balance. Equilibrium is disrupted such that the number of pro-angiogenic molecules are increased. Angiopoietins have been known to be recruited as well as VEGFs and platelet-derived growth factors (
References
- PMID 15893672.
- ^ PMID 20509945.
- ISBN 978-0-87893-558-1.
- PMID 10051567.
- PMID 24478758.
- ^ PMID 22922303.
- ^ ISBN 978-1-61504-120-6.
- PMID 20614597.
- ^ PMID 21606590.
- ISBN 0-306-47988-5.
- PMID 23500414.
- PMID 15562207.
- PMID 21334414.
- PMID 24412374.
- ^ Félétou, M. (2011). "Chapter 2, Multiple Functions of the Endothelial Cells.". The Endothelium: Part 1: Multiple Functions of the Endothelial Cells—Focus on Endothelium-Derived Vasoactive Mediators. San Rafael, CA: Morgan & Claypool Life Sciences.
- PMID 31108880.
- PMID 32565839.
- S2CID 12275550.
- S2CID 41226861.
- PMID 23409162.
- PMID 23536671.
- S2CID 7399513.
- PMID 19815705.
External links
- Angiopoietins at the U.S. National Library of Medicine Medical Subject Headings (MeSH)
- "angiopoietin.de: endothelia activation from bench to bedside". Medical School Hannover. Retrieved 2009-01-22.